Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAESTRAL - A Prospective, Multinational, Multicenter, Randomized, Double Blind, Double Dummy, Controlled Study Comparing the Efficacy and Safety of Moxifloxacin to That of Amoxicillin Clavulanic Acid for the Treatment of Subjects With Acute Exacerbations of Chronic Bronchitis.

NCT00656747 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00656747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00656747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAESTRAL - A Prospective, Multinational, Multicenter, Randomized, Double Blind, Double Dummy, Controlled Study Comparing the Efficacy and Safety of Moxifloxacin to That of Amoxicillin Clavulanic Acid for the Treatment of Subjects With Acute Exacerbations of Chronic Bronchitis.
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2008
Completion date
December 31, 2010
Enrollment
1,372 (actual)
Sites
220

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis